Welcome to our dedicated page for Definitive Healthcare news (Ticker: DH), a resource for investors and traders seeking the latest updates and insights on Definitive Healthcare stock.
Definitive Healthcare Corp. reports developments in healthcare market data, analytics, and commercial intelligence for organizations operating on the business side of healthcare. Its SaaS-based platform and related solutions support use cases such as market selection, go-to-market planning, provider targeting, affiliation analysis, prescription-pattern visibility, Key Opinion Leader identification, and workflow data enrichment.
Recurring news for DH includes quarterly and annual financial results, guidance commentary, customer wins and renewals across life sciences and health-system markets, expansions involving products such as Monocl and Population Intelligence, data-integration use cases, and investor conference presentations. Company updates also describe subscription revenue trends, adjusted profitability measures, cash flow, and commercial execution across new logos and existing customers.
Summary not available.
Summary not available.
Summary not available.
Definitive Healthcare has launched Atlas AI, a suite of proprietary analytics designed to enhance healthcare commercial intelligence. Utilizing a comprehensive dataset, Atlas AI incorporates 11 analytics focused on empowering clients to make informed business decisions. Key features include Affiliations Intelligence, which uncovers connections among healthcare providers, and RxDecision Insights, identifying prescribing patterns among physicians. Other tools enable deeper market understanding, such as Claims-Based Specialty and Predicted Locum Tenens. This initiative represents a significant investment in data science and machine learning, further positioning Definitive Healthcare as a leader in its sector.
Definitive Healthcare Corp. (Nasdaq: DH) announced that it will release its first quarter financial results on May 4, 2023, after market close. The company will hold a conference call at 5:00 PM ET to discuss these results, accessible via a live audio webcast on their Investor Relations website. Participants can also join by calling 1-877-407-3982. A replay of the call will be available until May 18, 2023. Definitive Healthcare specializes in healthcare commercial intelligence, providing clients with data-driven insights to navigate market opportunities.
Definitive Healthcare (Nasdaq: DH) has launched its Atlas Dataset on Snowflake Marketplace, enabling joint customers to integrate healthcare commercial intelligence into their workflows. This integration allows for improved decision-making regarding commercialization efforts. Key datasets available include:
- NRx & TRx: Prescribing Activity - Offers insights into prescription activity and physician performance.
- Atlas US Healthcare Reference & Affiliations Dataset - Provides contact info, financials, and organizational data.
- RxDecision Insights - Focuses on optimizing sales force allocation and understanding treatment decisions.
Both companies aim to enhance market understanding and drive new revenue opportunities through data integration.
Definitive Healthcare (Nasdaq: DH) has launched DefinitiveConnect on Salesforce AppExchange, allowing customers to access healthcare data directly within Salesforce. This integration enables users to import over 300 data elements into Salesforce Account, Contact, or Lead records, providing valuable insights on facility metrics and organizational news. CEO Robert Musslewhite emphasized that DefinitiveConnect streamlines access to healthcare data, enhancing decision-making for commercial strategies. The launch is expected to accelerate business transformation and growth opportunities for customers, as noted by David Lee from AppExchange. Definitive Healthcare specializes in delivering commercial intelligence solutions for the healthcare sector.
Definitive Healthcare Corp. (Nasdaq: DH) announced that its Chief Financial Officer, Rick Booth, will present at the Raymond James 2023 Institutional Investors Conference on March 7, 2023, at 2:50 p.m. Eastern Time. Investors can access a live webcast of the presentation on the Definitive Healthcare investor relations website. A replay will also be available for a limited time.
Definitive Healthcare is a leader in healthcare commercial intelligence, transforming data and analytics to help clients identify market opportunities. To learn more, visit definitivehc.com.
Definitive Healthcare reported a strong performance for Q4 and full year 2022, with revenue growth of 31% to $60.6 million in Q4, and a 34% increase to $222.7 million for the year. GAAP net income improved to $6.7 million, contrasting with a loss of $14.8 million in Q4 2021. Adjusted net income also rose to $10.5 million. For 2023, the company anticipates revenue between $249.0 million and $255.0 million, reflecting a 14% year-over-year increase. The launch of the Atlas Dataset and several key customer contracts signify substantial growth potential in the healthcare intelligence market.
GovForce, a technology company focused on government contractors, has secured $2.5 million in seed equity funding led by QED Investors and Humba Ventures. This funding aims to enhance its software platform designed to assist prime contractors with performance monitoring and compliance management. With government contractors managing approximately $700 billion annually in federal contracts, effective compliance is crucial. The GovForce platform addresses heightened security and reporting challenges in the industry, streamlining processes for subcontractor management, ultimately improving efficiency and performance.